Chrysamine G

Chrysamine G

SCHEMBL7706038

O=C(O)c1cc(N=Nc2ccc(-c3ccc(N=Nc4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
APP P05067 1/20 1.00
THRB P10828 1/20 1.00
RECQL P46063 1/20 1.00
BLM P54132 1/20 1.00
BLVRB P30043 2/20 0.85
PDE4A P27815 1/20 0.85
KDR P35968 1/20 0.85
HTT P42858 1/20 0.85
PHLPP2 Q6ZVD8 4/20 0.69
ALDH1A1 P00352 3/20 0.69
PTGS2 P35354 2/20 0.69
CYP2C9 P11712 2/20 0.69
TSHR P16473 2/20 0.69
PTGS1 P23219 1/20 0.69
HSD17B10 Q99714 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C19 P33261 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chrysamine G SCHEMBL7706036 1.00 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB
Chrysamine G SCHEMBL15818025 0.98 MEN1 (0.96) MEN1KMT2ATDP1APPTHRB
Chrysamine G SCHEMBL15818022 0.98 MEN1 (0.96) MEN1KMT2ATDP1APPTHRB
SCHEMBL7711257 0.95 MEN1 (0.90) MEN1KMT2ATDP1APPTHRB
SCHEMBL7711260 0.95 MEN1 (0.90) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL25118 0.92 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL29861404 0.92 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL29385751 0.92 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL29378994 0.92 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL25119 0.92 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417178-B1 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits UNIVERSITY OF PITTSBURGH 2002-07-09 US disclosed
EP-1110945-A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition UNIVERSITY OF PITTSBURGH (US) 2001-06-27 EP disclosed
US-6168776-B1 Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition UNIVERSITY OF PITTSBURGH 2001-01-02 US disclosed
US-6133259-A DIAGNOSIS OF ALZHEIMER'S DISEASE UNIVERSITY OF PITTSBURGH (US) 2000-10-17 US disclosed
US-6114175-A AMYLOID-BINDING COMPOUNDS WHICH ARE NON-AZO DERIVATIVES OF CHRYSAMINE G TO DETERMINE DEGREE OF BRAIN DEPOSITS QUANTITATIVELY CHARACTERIZED BY AMYLOIDOSIS; DOWN'S SYNDROME; PREVENT CELL DEGENERATION; RADIOACTIVE IMAGING UNIVERSITY OF PITTSBURGH (US) 2000-09-05 US disclosed
US-4058607-A DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES AIRWICK INDUSTRIES, INC. (US) 1977-11-15 US disclosed
US-3966900-A INSECTICIDES AIRWICK INDUSTRIES, INC. (US) 1976-06-29 US disclosed